Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1123
https://www.valueinhealthjournal.com/article/S1098-3015(16)32489-5/fulltext
Title :
Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32489-5&doi=10.1016/j.jval.2016.09.1123
First page :
A540
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1054